Chronoscreen™ movement disorder models generate positive drug data

Our high-resolution movement disorder model system in C.elegans has shown clear drug effects. Movement defects in animals genetically modified to carry human neurodegenerative disease proteins were positively affected by a number of screened compounds. Throughput is now being increased so that a large library of compounds can be assessed for potential efficacy against a range of movement disorders created in our laboratory.